Chaste berry herb contains several different constituents, including flavonoids, iridoid glycosides, and terpenoids. Chaste berry (the fruit of a small Eurasian tree, also called Vitex agnus) does not contain hormones. The benefits of chasteberry stem from its actions upon the pituitary gland. Chaste berry keeps prolactin secretion in check. The ability to decrease mildly elevated prolactin levels may benefit some women with breast tenderness associated with PMS. Chasteberry may also be helpful in menopause and cyclic mastalgia. New research indicates that certain compounds in the plant may have activity similar to the brain chemical dopamine.
Enzymatic Therapy - Buy Chaste Berry
Extract 225 per pill

Supplement Facts
Serving Size 1 capsule
Chaste berry Tree - 225
mg each pill
(Vitex agnus-castus) Berry Extract
Standardized to contain a minimum of 0.5% agnuside (1,130 mcg per capsule)
Recommendations: One capsule Chasteberry extract two
times daily.
Click here to buy Chaste Berry supplement product, Hot Flash with chaste berry
extract, or to see a complete list of high quality products
Hormone replacement therapy and menopause
Recent studies indicate that long term replacement with Premarin (horse
derived estrogens) and synthetic progesterone increases the risk for heart disease,
cancer, blood clots and gallbladder disease.
The field of hormone or herbal therapy during or after menopause is very
complicated and there is no consensus within the medical community regarding the
best option for long term therapy. The medical community seems to be shifting
its viewpoint on hormone replacement. It appears that most traditional doctors
now prefer using low doses of hormones for a brief period of time to treat
menopausal symptoms, but prefer not to continue hormone replacement therapy indefinitely as in the past.
Chaste berry and other herbs offer some hope as weak alternatives.
Mastalgia, breast pain
Treatment of cyclical mastalgia with a solution containing a Vitex agnus castus extract: results of a placebo-controlled double-blind study.
Breast. 1999 Aug.
In a placebo-controlled, randomized, double-blind study the efficacy of a
chaste berry extract-containing solution was investigated in patients suffering
from cyclical mastalgia. Patients had mastalgia on at least 5 days in the
pre-treatment cycle. During this cycle and during treatment (3 cycles; 2 x 30
drops/day), the intensity of mastalgia was recorded once per cycle using a
visual analogue scale (VAS). Chaste berry appears effective and was well tolerated and
further evaluation of this agent in the treatment of cyclical mastalgia is
warranted.
The PMS relief herb?
PMS (premenstrual syndrome) is the name of a group of symptoms
that start 7 to 14 days before a period and stop soon after the period begins.
Most women feel some discomfort before their periods but those with
PMS may feel
so anxious, depressed or uncomfortable that they can't cope at home or at work.
PMS seems to be linked in part to changes in
hormone levels during the menstrual cycle, and perhaps partly due to elevated levels of a
pituitary hormone called prolactin.
Several studies over the past few years have
indicated that extracts from chasteberry help with symptoms of PMS. In a recent study done in Germany, 86 patients
with PMS were treated daily with one tablet (20 mg chasteberry extract) during three menstrual cycles.
At the end of the study, many PMS-related symptoms were significantly reduced by treatment
with chasteberry in the majority of the participants. No serious adverse effects were reported. The
researchers say, "Extract of chaste berry is an effective and well
tolerated treatment for the relief of symptoms of the premenstrual syndrome."
How it works is not clear, but one
possibility is that it may reduce the release of prolactin from the pituitary gland.
At least two previous studies have also shown
the beneficial effects of chasteberry in relation to PMS. Other natural therapies that
could be helpful include exercise, yoga, B vitamins, calcium supplements, and reduction of
simple sugars, alcohol and caffeine.
Fluoxetine versus Vitex agnus castus extract
in the treatment of premenstrual dysphoric disorder.
Hum Psychopharmacol. 2003.
Clinical trials have demonstrated that serotonin reuptake inhibitors (SRIs) and
the extract of chaste berry are effective for the treatment of
premenstrual dysphoric disorder (PMDD). The aim of the present study was to compare the
efficacy of fluoxetine, a selective serotonin reuptake inhibitor (SSRI), with
that of the chaste berry extract, a natural choice. After a period of 2 screening months
to screen the patients for suitability, 41 patients with PMDD according to
DSM-IV were recruited into the study. The patients were randomized to fluoxetine
or chaste berry for 2 months of single-blind, rater- blinded and prospective
treatment period. At
endpoint a similar percentage of
patients responded to fluoxetine (68%) and chaste berry (57%). There
was no statistically significant difference between the groups with respect to
the rate of responders. This preliminary study suggests that patients with PMDD
respond well to treatment with both fluoxetine and chaste berry. However, fluoxetine was
more effective for psychological symptoms while the extract diminished the
physical symptoms.
Prostate cancer
A Vitex agnus-castus extract inhibits cell growth and
induces apoptosis in prostate epithelial cell lines.
Planta Med. 2005.
Institute of Pharmaceutical Biology, University of Basel, Schonbeinstrasse
Basel, Switzerland.
Extracts of chaste berry fruits are described to have
beneficial effects on disorders related to hyperprolactinemia (cycle disorders,
premenstrual syndrome). A chaste berry extract has recently been shown to
exhibit antitumor activities in different human cancer cell lines. In the
present study, we explored the antiproliferative effects of a chaste berry
extract with a particular focus on apoptosis-inducing and potential cytotoxic
effects. Our data suggest that chaste berry contains components that inhibit
proliferation and induce apoptosis in human prostate epithelial cell lines. The
extract may be useful for the prevention and/or treatment not only of benign
prostatic hyperplasia but also of human prostate cancer.
Review of chasteberry side
effects, safety, risks, toxicity
No major side effects or toxicity has been reported in the medical literature
thus far.
Chaste Berry
research studies
Chasteberry tree -- pharmacology and clinical indications.
Phytomedicine. 2003.
Extracts of the fruits of chaste tree are
widely used to treat premenstrual symptoms. Double-blind placebo-controlled
studies indicate that one of the most common premenstrual symptoms, i.e.
premenstrual mastodynia (mastalgia) is beneficially influenced by an chaste
berry extract. Premenstrual mastodynia is most likely due to a
latent hyperprolactinemia, i.e. patients release more than physiologic amounts
of prolactin in response to stressful situations and during deep sleep phases
which appear to stimulate the mammary gland. Premenstrually this unphysiological
prolactin release is so high that the serum prolactin levels often approach
heights which are misinterpreted as prolactinomas. Since chasteberry extracts
were shown to have beneficial effects on premenstrual mastodynia serum prolactin
levels in such patients were also studied in one double-blind,
placebo-controlled clinical study. Serum prolactin levels were indeed reduced in
the patients treated with the chasteberry extract. The search for the prolactin-suppressive
principle(s) in chasteberry yielded a number of compounds with dopaminergic
properties.
The search for the chemical identity of the chasteberry dopaminergic compounds
resulted in isolation of a number of diterpenes of which some clerodadienols
were most important for the prolactin-suppressive effects. They were almost
identical in their prolactin-suppressive properties than dopamine itself. Hence,
it is concluded that dopaminergic compounds present in chasteberry are
clinically the important compounds which improve premenstrual mastodynia and
possibly also other symptoms of the premenstrual syndrome.
Evidence for estrogen receptor beta-selective activity of Vitex agnus-castus and isolated flavones.
Planta Med. 2003.
Recent cell culture experiments indicated that extracts of Vitex agnus-castus
(chaste berry) may contain yet unidentified phytoestrogens. Estrogenic actions
are mediated via estrogen receptors (ER). To investigate whether chasteberry
compounds bind to the currently known isoforms ERalpha or ERss, ligand binding
assays (LBA) were performed. Subtype specific ER-LBA revealed a binding of
chasteberry to ERss only. To isolate the ERss-selective compounds, the extract
was fractionated by bio-guidance. The flavonoid apigenin was isolated and
identified as the most active ERss-selective phytoestrogen in chasteberry .
Other isolated compounds were vitexin and penduletin. These data demonstrate
that the phytoestrogens in chasteberry are ERss-selective.
Vitex ( Chasteberry ) Extract 5% Vitexin